Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women

Vilaprisan is a novel selective progesterone receptor modulator for the long‐term treatment of uterine fibroids and endometriosis. This study investigated the pharmacokinetics, safety, and tolerability of vilaprisan in healthy Chinese postmenopausal women. Twelve participants received multiple doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongzhong, Jiang, Ji, Chen, Zhaozhao, Zhang, Yunhui, Li, Jinyi, Hoechel, Joachim, Rohde, Beate, Zimmermann, Torsten, Schultze‐Mosgau, Marcus‐Hillert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247050/
https://www.ncbi.nlm.nih.gov/pubmed/32716091
http://dx.doi.org/10.1002/cpdd.851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247050/
https://www.ncbi.nlm.nih.gov/pubmed/32716091
http://dx.doi.org/10.1002/cpdd.851

Ejemplares similares